Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Disease”

2,253 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,253 results

Early research (Phase 1)Study completedNCT05984992
What this trial is testing

The First-in-human Study of SRN-001 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis
siRNAgen Therapeutics Inc. 25
Testing effectiveness (Phase 2)Ended earlyNCT01628900
What this trial is testing

Prospective Study in the Emergency

Who this might be right for
Pyelonephritis
Assistance Publique - Hôpitaux de Paris 23
Not applicableStudy completedNCT00569907
What this trial is testing

Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide

Who this might be right for
Diabetes Mellitus Type 2
HealthPartners Institute 18
Early research (Phase 1)Study completedNCT00072592
What this trial is testing

An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies

Who this might be right for
Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 10
Post-approval studies (Phase 4)UnknownNCT04818489
What this trial is testing

Colchicine and Post-COVID-19 Pulmonary Fibrosis

Who this might be right for
Covid19Pulmonary Fibrosis Interstitial
ClinAmygate 260
Post-approval studies (Phase 4)Not Yet RecruitingNCT07141810
What this trial is testing

Efficacy and Safety of Early Antifibrotic Therapy for Non-progressive Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Shanghai Pulmonary Hospital, Shanghai, China 104
Large-scale testing (Phase 3)Looking for participantsNCT07459790
What this trial is testing

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

Who this might be right for
ICHunner Type Interstitial CystitisBladder Pain Syndrome
JSC NextGen 180
Not applicableUnknownNCT05095090
What this trial is testing

Study of Hospitalised Patients With Acute Respiratory Conditions

Who this might be right for
Acute Respiratory DiseaseCOPD Exacerbation AcuteAsthma+1 more
University of Leicester 130
Not applicableStudy completedNCT03386097
What this trial is testing

Interstitial Fluid in the Development of Cardiovascular Disease

Who this might be right for
Type2 DiabetesAtherosclerosis
Karolinska University Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT07201922
What this trial is testing

Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Who this might be right for
Familial Pulmonary FibrosisInterstitial Lung AbnormalitiesInterstitial Lung Diseases
Boehringer Ingelheim 80
Testing effectiveness (Phase 2)Looking for participantsNCT07447102
What this trial is testing

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Dragonboat Biopharmaceutical Company Limited 96
Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06700421
What this trial is testing

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Who this might be right for
Unresectable Locally Advanced Non-small Cell Lung Cancer
Wei Zhou 32
Not applicableWithdrawnNCT02187393
What this trial is testing

Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisHealthy
University of Colorado, Denver
Post-approval studies (Phase 4)Study completedNCT02143687
What this trial is testing

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance

Who this might be right for
Precapillary Pulmonary HypertensionInterstitial Lung Disease
University of Zurich 30
Not applicableNot Yet RecruitingNCT07836764
What this trial is testing

Validation of 1 Minute Sit-to Stand Test for Assessment of Breathlessness at Exertion in Individuals With Chronic Lung Disease

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)Asthma (Diagnosis)Interstitial Lung Disease (ILD)
Jacob Sandberg 120
Testing effectiveness (Phase 2)Looking for participantsNCT05746039
What this trial is testing

Feasibility of Semaglutide in Advanced Lung Disease

Who this might be right for
ObesityInterstitial Lung DiseaseChronic Obstructive Pulmonary Disease+2 more
University of Pennsylvania 8
Not applicableStudy completedNCT03324503
What this trial is testing

Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

Who this might be right for
Sarcoidosis, Pulmonary
Celgene 8
Not applicableStudy completedNCT00708266
What this trial is testing

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines

Who this might be right for
ObesityType 2 Diabetes Mellitus
Medical University of Graz 10
Large-scale testing (Phase 3)UnknownNCT03857854
What this trial is testing

Efficacy and Safety of Pirfenidone in Patient With Dermatomyositis Interstitial Lung Disease (Dm-ILD)

Who this might be right for
Dermatomyositis Interstitial Lung Disease (Dm-ILD)
Beijing Continent Pharmaceutical Co, Ltd. 152
Next Page